AstraZeneca Reports Strong Growth in Q3 2024 20d ago AZN The Fly Unusually active option classes on open November 12th 21d ago HD WT Market News AstraZeneca (AZN) Raises 2024 Forecast After Strong Q3 21d ago AZN The Fly AstraZeneca reports Q3 reported EPS 92c, consensus $1.03 ...
The US Food and Drug Administration (FDA) has approved AstraZeneca's human monoclonal antibody, Imfinzi (durvalumab), to treat limited-stage small cell… 05 Dec 2024 04 Dec 2024 CEO of UnitedHealthcare, Brian Thompson, shot dead in New York City The CEO of US healthcare insurance firm ...
The National University Health System (NUHS) and Sahlgrenska University Hospital have formed a strategic partnership with technology partners AstraZeneca, Ericsson and Business Sweden to launch the Global Health Innovation Network (GHIN) that aims to drive global healthcare innovation. Nov 20, 2024 |...
Focuses on AstraZeneca, the pharmaceutical company formed by the merger of Great Britain's Zeneca and Sweden's Astra. Projected annual sales of the combined company; Financial implications of the deal; Strategic interests of AstraZeneca; Its agrochemicals business.Layman...
Caixin Global provides the latest China news headlines on politics, economy, business and finance with insight and in-depth analysis.
News ZTE Corporation Log in Sign up Search US Congress to Vote on Bill Providing $3 Billion to Replace Chinese Telco Equipment Dec. 10 MT US votes on $3 billion to remove Chinese telecom equipment Dec. 09 FW US House to vote to provide $3 billion to remove Chinese telecoms equipment...
Here you will find the latest news, articles on Science and Technology. A look at the innovation and technologies that are shaping the future and changing the world.
AstraZeneca says the spray could be available "as soon as next flu season." Sep 20 FDA approves Apple AirPods Pro 2 to be used as hearing aids Tech giant's latest AirPods will soon function as hearing aids for people with mild to moderate hearing loss. ...
AstraZeneca spokeswoman confirmed that the vaccine’s trails in the U.S. remain on hold, saying that the company will “work with the FDA to facilitate review of the information and the agency will decide when the U.S. trial can resume.”— Noah Higgins-Dunn ...
AstraZeneca was expected to deliver over 80 million doses to European countries by the end of March. However, the country is having problems with production and warns Eu countries that it might not be able to deliver more than 80 million doses. The reason AstraZeneca is supplying vaccines is...